Acceleron Pharma
Why Robinhood?
You can watch XLRN and buy or sell other stocks, ETFs, and their options commission-free!About XLRN
Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension.
XLRN Key Statistics
Stock Snapshot
As of today, Acceleron Pharma(XLRN) shares are valued at $178.75. The company's market cap stands at 10.93B, with a P/E ratio of -42.53.
On 2026-05-18, Acceleron Pharma(XLRN) stock opened at —, reached a high of —, and a low of —.
The Acceleron Pharma(XLRN)'s current trading volume is 0, compared to an average daily volume of 1.94M.
During the past year, Acceleron Pharma(XLRN) stock moved between $111.29 at its lowest and $189.99 at its peak.
During the past year, Acceleron Pharma(XLRN) stock moved between $111.29 at its lowest and $189.99 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.